Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
General anesthesia + opioid analgesia refers to the combined use of general anesthetic agents and opioid analgesics during surgical procedures. General anesthetics induce a reversible state of unconsciousness, amnesia, and immobility, typically through intravenous or inhalational agents such as propofol, sevoflurane, desflurane, or isoflurane. Opioid analgesics (such as fentanyl, morphine, hydromorphone) are administered concurrently to provide potent pain relief by binding to opioid receptors in the central nervous system. This combination is foundational in balanced or multimodal anesthesia practice—using multiple drugs at lower doses to maximize efficacy while minimizing side effects. The mechanism of action involves general anesthetics depressing central nervous system activity (primarily via GABAergic pathways), while opioids activate mu-, delta-, and kappa-opioid receptors to inhibit nociceptive transmission and alter pain perception[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on general anesthesia + opioid analgesia.